Market Research Reports and Industry Reports

Winning Strategies in Molecular Diagnostics: Integrating New Technology Planning with Business and Corporate Strategies--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

This new seven-country study from VPGMarketResearch contains 1,050 pages, 96 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years.

Highlights

- Business and technological trends in seven major markets: France, Germany, Italy, Japan, Spain,
  UK, and US
- Five-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Profiles of market players and start-up firms developing innovative technologies
  and products
- Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.  The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches.  The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.  Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage

- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA

Worldwide Market Overview

- Laboratories performing DNA sequencing and molecular diagnostic testing by country and market
  segment.

- Five-year test volume and sales projections by country.

Market Segmentation Analysis

- Sales and market shares of major suppliers of molecular diagnostic reagent kits and components.

- Five-year test volume and sales forecasts for major applications, including:

- Infectious Diseases        - Forensic Testing
- Cancer                          - Paternity Testing/HLA Typing
- Genetic Diseases           - Others

- Five-year test volume and sales projections for over 30 NAT assays.

- A comprehensive analysis of the sequencing market, by country and laboratory segment,
  including:

- Industrial        - Academic
- Government   - Commercial

- Detailed market segmentation analysis, including review of the market dynamics, trends,
  structure, size, growth and major suppliers, by country.

Product/Technology Review

- Comparison of leading molecular diagnostic analyzers from Abbott, Beckman Coulter, BD,
  Bio-Rad, Gen-Probe, Roche, Tecan and other suppliers.

- Extensive review of molecular diagnostic technologies, test formats, detection methodologies,
  trends in testing automation and over 30 target/signal amplification methods, including:

- PCR     - bDNA
- SDA     - NASBA
- TMA    - SSSR, and others
- LCR

- Worldwide listings of companies, universities and research centers developing new molecular-
   diagnostic technologies and products.

Competitive Assessments

- Extensive strategic assessments of major suppliers and emerging market entrants,
  including their sales, product portfolios, marketing tactics, collaborative arrangements and
  new technologies/products in R&D.

- Comprehensive listings of companies developing and marketing molecular diagnostics products,
  by test and application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal
  during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

- Business planning issues and concerns.

Methodology

This report is based on a combination of primary and secondary information sources, including interviews with laboratory directors and executives of leading diagnostic companies and start-up firms developing innovative technologies and products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product
and financial literature, as well as VPGMarketResearch’s proprietary data base was conducted.


Introduction

Worldwide Market And Technology Overview


A. DNA Sequencing

1. Introduction
2. Sequencing Methods
3. Autoradiography
4. The Human Genome Project
5. Sequencing Automation
6. Image Scanners
7. Fluorescent Detection
8. Gene Profiling
9. Gene Expression
10. Polymorphism Screening
11. Protein Interaction Networks

B. DNA And RNA Probe Technology

1. Basic Principles
2. Probe Preparation
3. The DNA Probe Test
a. Sample Preparation
b. Hybridization
c. Separation
d. Detection/Measurement
4. Test Formats
a. Filter Hybridization
b. Southern Blot
c. Northern Blot
d. In Situ Hybridization
e. Others
5. Labeling Techniques
6. Amplification Methods
O
Polymerase Chain Reaction
- Temperature Cyclers
Table of Contents
(continued)
- PCR Variations
* Immuno-PCR
* QC-PCR
* DAP-PCR
O
Strand Displacement Activation
O
TMA
O
Ligase Chain Reaction
O
Branched DNA
- Hybridization Protection Assay
O
Nucleic-Acid Sequence-Based Amplification
O
Self-Sustained Sequence Replicase
O
Others
- Ampliprobe
- CAR
- CAS
- CPT
- Dendritic Polymer Technology
- ISO-CR
- LAT
- Probe Networks
- RAMP
- Repair Chain Reaction
- Rolling Circles
- Sequence Independent Gene Amplification
- Sequence Initiation Reaction
- SISPA
- Solid Phase Amplification

C. Detection Technologies

1. Radioactive Methods
a. Overview
b. Major Isotopes
O
P-32
O
S-35
O
H-3
O
I-125
2. Non-Isotopic Methods
a. Enzymatic Labels
b. Chemical Labeling
O
Indirect Chemical Labeling
O
Direct Chemical Labeling
Table of Contents
(continued)
c. Fluorescence
d. Chemiluminescence
e. Electrical Conductivity

D. Instrumentation Review

1. Abbott LCx
2. Beckman Coulter/Biomek FK
3. Becton Dickinson SDA
4. Bio-Rad GeneScope
5. Gen-Probe Tigris
6. Roche Cobas Amplicor
7. Tecan LS Series

E. Biochips: Genosensors, Microarrays, and
Labs-on-the-Chip


- Liquid Transportation and Mixing
- Separation
- Reaction
- Detection

F. Pharmacogenomics

G. Major Applications


1. Microbiology/Infectious Diseases
a. Overview
b. Major Infectious Diseases
* AIDS
O
Structure and Composition
O
Classification
O
AIDS Origins
O
Animal Lentivirus Systems
O
Virus Receptors
O
HIV Infections in Humans
- Pathogenesis and Pathology
O
CD4T Lymphocytes and Memory Cells
O
Monocytes and Macrophages
O
Lymphoid Organs
O
Neural Cells
O
Viral Coinfections
- Clinical Findings
O
Plasma Viral Load
Table of Contents
(continued)
O
Pediatric AIDS
- Neurologic Disease
- Opportunistic Infections
- Cancer
O
Immunity
- Virus Isolation
- Serology
- Viral Nucleic Acid/Antigen Detection
O
Epidemiology
- Worldwide Spread of AIDS
- United States
- Routes of Transmission
O
DNA Probes
- Overview
- Quantitative PCR
- In Situ PCR
- Needed Improvements
O
Viral Load/Drug Resistance Testing
O
Genotype and Phenotype Testing
O
Blood Banking Considerations
* Adenovirus
O
Background
O
Diagnostic Tests
O
Vaccines and Drugs
O
Adeno-Associated Viruses (AAV)
* Anthrax/Bacillus Anthracis
O
Background
O
Diagnostic Tests
O
Vaccines and Drugs
* Babesiosis
O
Background
* BEA and Other Bartonella Diseases
O
Background
O
Diagnostic Tests
O
Vaccines and Drugs
* Chagas Disease
O
Background
Table of Contents
(continued)
* Campylobacter
O
Background
O
Diagnostic Tests
- Culture Identification
O
Vaccines and Drugs
* Chlamydia
O
Background
- Chlamydia psittaci
- Chlmaydia pneumoniae
- Chlamydia trachomatis
O
Diagnostic Tests
O
Vaccines and Drugs
* Creutzfeldt-Jakob’s Disease
O
Background
O
Blood Transmission
O
Diagnostic Tests
O
Major Commercial and Academic Players
- Bayer
- Disease Sciences/Bio Tec Global
- Imperial College School of Medicine
- Ortho-Clinical Diagnostics
- Pall
- ProMetic Life Sciences
- Proteome Sciences/Idexx
- Q-One Biotech
- Serono
- U.S. Agricultural Research Service
O
Drugs
O
Vaccines
* Cytomegalovirus
O
Background
- Chorioretinitis
- Gastrointestinal
- Central Nervous System Disease
O
Diagnostic Tests
O
Vaccines and Drugs
* Ebola Virus
O
Background
- Epidemiology
- Clinical Syndromes


List Of Tables

Major Companies Developing or Marketing AIDS Molecular
Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Campylobacter
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Chlamydia
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing CMV Molecular
Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular
Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Hepatitis
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Herpes
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Legionella
Molecular Diagnostic And Other Direct
Identification Tests
List of Tables
(continued)
Major Companies Developing or Marketing Lyme
Disease Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Mycoplasma
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Papilloma
Virus Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Pneumonia
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Salmonella
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Shigella
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Streptococci
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Toxoplasmosis
Molecular Diagnostic And Other Direct
Identification Tests
Major Companies Developing or Marketing Tuberculosis
Molecular Diagnostic And Other Direct
Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer
Molecular Diagnostic Tests


United States Coal Winning Machine Market Report 2016

Notes:Sales, means the sales volume of Coal Winning MachineRevenue, means the sales value of Coal Winning MachineThis report studies sales (consumption) of Coal Winning Machine in United States market, focuses

USD 3800View Report

Global Coal Winning Machine Market Research Report 2016

Notes:Production, means the output of Coal Winning MachineRevenue, means the sales value of Coal Winning MachineThis report studies Coal Winning Machine in Global market, especially in North America, Europe, China,

USD 2900View Report

Winning Strategies in Molecular Diagnostics: Integrating New Technology Planning with Business and Corporate Strategies--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

This new seven-country study from VPGMarketResearch contains 1,050 pages, 96 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the

USD 24500View Report

Wealth in the Philippines: HNW Investors 2016 ; Understanding HNW investors and wealth management strategies in the Philippines.

Filipino HNW investors are mainly drawn from affluent families, being owners of successful and longstanding business empires. Newer entrepreneurial and high-earning individuals have begun to reshape the market along more

USD 3450View Report

Future Horizons and Growth Strategies in the US Clinical Chemistry and Immunodiagnostic Markets: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Complete report $11,500. DataPack (test volumes, sales forecasts, supplier shares) $7,500.VPGMarketResearch.coms new report is a strategic analysis of major business opportunities emerging in the US clinical chemistry and immunodiagnostic markets

USD 11500View Report

Future Horizons and Growth Strategies in the UK Clinical Chemistry and Immunodiagnostic Markets: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

VPGMarketResearch.coms new report is a strategic analysis of major business opportunities emerging in the UK clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in

USD 6100View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

Discount on PDF and Enterprise Wide Licence reports
  • PDF $ 24500    $ 24500
  • Global Licence $ 53900    $ 53900
  • DataPack $ 15900    $ 15900
$ 24500

Reports Details

Published Date : Aug 2016
No. of Pages :1050
Country :Global
Category :Healthcare
Publisher :VPGMarketResearch.com
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment